Jan Leschly's Net Worth
$54.6 Million
Who is Jan Leschly?
Jan Leschly has an estimated net worth of $54.6 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, VIACOM INC, DYNAVAX TECHNOLOGIES CORP, Vanda Pharmaceuticals Inc., Aviragen Therapeutics, Inc., and AMERICAN EXPRESS CO.
SEC CIK
Jan Leschly's CIK is 0001204568
Past Insider Trading and Trends
2004 was Jan Leschly's most active year for acquiring shares with 11 total transactions. Jan Leschly's most active month to acquire stocks was the month of March. 2011 was Jan Leschly's most active year for disposing of shares, totalling 3 transactions. Jan Leschly's most active month to dispose stocks was the month of December. 2007 saw Jan Leschly paying a total of $3,004,908.06 for 55,027 shares, this is the most they've acquired in one year. In 2012 Jan Leschly cashed out on 6,854 shares for a total of $183,104.61, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -159.14K |
$6.74 | -$1,071,928.81 |
0
|
Jul 15 - Jul 16
| |||
Form 4
| -7.78% | -13.42K |
$6.13 | -$82,214.79 | 159.14K |
Jul 7 - Jul 8
| |||
Form 4
| -30.72% | -76.51K |
$6.20 | -$474,506.41 | 172.56K |
Jul 2 - Jul 6
| |||
Form 4
| -24.91% | -82.64K |
$6.72 | -$555,677.70 | 249.07K |
Jun 30 - Jul 1
| |||
Form 4
| -67.64% | -693.30K |
$6.86 | -$4,757,413.02 | 331.71K |
Jun 26 - Jun 29
| |||
Form 4
| -4.79% | -51.52K |
$6.50 | -$334,921.01 | 1.03M |
Jun 24 - Jun 25
| |||
Form 4
| -3.97% | -44.46K |
$6.37 | -$283,190.70 | 1.08M |
Jun 22 - Jun 23
| |||
Form 4
| -8.98% | -110.61K |
$6.54 | -$723,515.11 | 1.12M |
Jun 19
| |||
Form 4
| -11.71% | -163.39K |
$6.44 | -$1,052,398.99 | 1.23M |
Jun 17 - Jun 18
| |||
Form 4
| -30.25% | -605.00K |
$7.14 | -$4,321,999.60 | 1.4M |
Jun 15 - Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIACOM INC (PARA) Snapshot price: $10.13
InvestorJan Leschly owns 51,690 units of Class B common stock which is worth $523,619.70.acquired a total of 8,880 shares in VIACOM INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4/A
| +20.74% | 8.88K |
—
|
—
| 51.69K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
| +184.12% | 889.97K |
—
|
—
| 1.37M |
Feb 24
| |||
Form 4
| +16.01% | 66.7K |
$7.50 | $500,250.00 | 483.37K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $5.12
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.30% | -424.15K |
$25.18 | -$10,680,097.00 | 1.89M |
Dec 12
| |||
Form 4
| -12.34% | -326.32K |
$26.40 | -$8,614,980.00 | 2.32M |
Dec 11
| |||
Form 4
| -10.19% | -300.00K |
$14.18 | -$4,254,000.00 | 2.64M |
Nov 27
| |||
Form 4
| -9.25% | -300.00K |
$14.12 | -$4,236,000.00 | 2.94M |
Nov 22
| |||
Form 4
| -1.52% | -50.00K |
$14.55 | -$727,500.00 | 3.24M |
Nov 21
| |||
Form 4/A
| -41.55% | -320.00K |
$14.77 | -$4,612,000.00 | 450.13K |
Nov 17 - Nov 20
| |||
Form 4
| -3.19% | -320.00K |
$14.77 | -$4,612,000.00 | 9.72M |
Nov 17 - Nov 20
| |||
Form 4
| +233.89% | 3.61M |
—
|
—
| 5.16M |
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aviragen Therapeutics, Inc. (VXRT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 30.79M |
—
|
—
| 30.79M |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||